Wednesday, February 4, 2026

AI Spending Concerns Deepen Tech Slump; Asia Retreats

U.S. equities concluded Wednesday's regular session largely flat, with the S&P 500 unchanged, yet post-market trading continues to reveal a deepening divide, primarily driven by investor anxieties surrounding the soaring costs of the AI race and persistent headwinds in the chip sector. This sentiment is already spilling over into Asian markets, which are showing significant retreats.

Despite delivering solid fourth-quarter revenue and EPS beats, Google parent GOOGL remained under pressure in after-hours trading. The market is reacting negatively to the company's aggressive 2026 capital expenditure forecast, targeting up to $185 billion for its deepening AI investments. This substantial spending plan has reignited concerns about the immediate profitability and return on investment of the AI revolution, mirroring earlier scrutinies of Microsoft's (MSFT) own significant AI-related capex.

Adding to the tech sector's struggles, the semiconductor space is facing a challenging evening. Following the day's sharp 16.7% plunge in Advanced Micro Devices (AMD), chip supplier QCOM slid over 6% after hours, issuing a weak second-quarter revenue and profit forecast due to a global memory chip shortage impacting mobile sales. Further compounding this, ARM shares also plunged significantly post-close, down 8%, after its licensing revenue missed estimates and smartphone chip sales disappointed, exacerbating fears of an extended chip sector downturn. This cautious outlook is extending into global markets, with Asian stocks already in retreat as traders reconsider tech investments amid AI disruption worries.

However, pockets of strength emerged elsewhere. Japanese tech and entertainment giant SONY reported estimate-beating profit growth and hiked its forecast, showcasing resilience. Financial services firm PRU saw its fourth-quarter profit jump on underwriting strength, while RNECY highlighted AI growth potential in its Q4 earnings call. Nonetheless, the prevailing post-market narrative remains one of caution, as investors weigh impressive AI-driven revenue growth against the enormous capital required to fund it.

AI Spending Fears Weigh Post-Close; Palantir, TTM Offer Pockets of Strength

U.S. equities concluded Wednesday's regular session largely flat, with the S&P 500 closing unchanged. However, post-market trading continues to reflect a cautious sentiment, particularly within the tech sector, as investors grapple with the high costs of the AI race and chip market headwinds.

Google parent GOOGL remained under pressure in after-hours trading despite beating Q4 revenue and EPS estimates. The market reacted negatively to the company's aggressive 2026 capital expenditure forecast, targeting up to $185 billion for AI investments, reigniting concerns about the immediate profitability of the AI revolution. Adding to the tech sector's struggles, chip supplier QCOM slid over 6% after hours, issuing a weak Q2 revenue and profit forecast due to a global memory chip shortage impacting mobile sales. These developments, along with earlier a 16.7% plunge in AMD, are setting a challenging tone for tech heading into the next session.

However, not all AI-related news was negative. Data analytics firm PLTR saw its CEO highlight robust revenue growth driven by existing clients significantly increasing their spending on AI solutions, suggesting effective monetization in certain niches. Similarly, TTM TTMI reported strong demand tied to AI and defense spending, providing another positive signal. Elsewhere, oil prices slid after Washington and Tehran agreed to hold talks, easing de-escalation hopes. Looking ahead, Asian markets are already faltering overnight, mirroring concerns about the exploding costs of AI investment that spooked global tech investors.

Google's AI Spending Spooks Tech Post-Close; Chip Sector Under Pressure

U.S. equities concluded Wednesday's regular session largely flat, with the **S&P 500** closing unchanged, masking a day of significant sector rotation and underlying volatility. However, post-market trading saw a renewed wave of caution wash over the tech sector, dominated by investor reaction to heavy AI-related spending and chip market headwinds.

Despite beating fourth-quarter revenue and EPS estimates, Google parent GOOGL saw its shares come under pressure in after-hours trading. The market reacted negatively to the company's aggressive 2026 capital expenditure forecast, targeting up to $185 billion primarily for its deepening AI investments. This reignited concerns about the immediate profitability and return on investment (ROI) of the AI race, mirroring earlier scrutinies of **Microsoft's (MSFT)** own significant AI-related capex plans discussed throughout the day.

Adding to the tech sector's struggles, chip supplier QCOM slid over 6% after hours, issuing a weak second-quarter revenue and profit forecast due to a global memory chip shortage impacting mobile sales. This compounded the day's earlier significant plunge in AMD, which ended down 16.7% after its earnings forecast disappointed investors and triggered broad selling across the semiconductor space. The broader software sector continued to grapple with fears of AI disruption, with names like CRM and **Thomson Reuters (TRI)** reflecting ongoing investor caution. Even **Arm Holdings (ARM)** fell post-earnings, highlighting the high bar for AI-centric companies.

However, the day wasn't entirely negative. Pharmaceutical giant LLY maintained its robust rally, fueled by blockbuster GLP-1 drug sales and strong 2026 guidance. Chinese tech giant BIDU provided a positive surprise post-close, announcing a $5 billion share repurchase program and its first-ever dividend payment, expected in 2026. After-hours, SNAP shares surged after beating sales estimates, and ELF also rose after raising its annual forecasts on strong demand for affordable cosmetics. Pockets of strength also emerged in industrials and utilities during the regular session, offering a counterpoint to tech's struggles. Nonetheless, the overwhelming post-market sentiment for technology leans cautious as investors digest the heavy price tag of the AI revolution.

Google's AI Spending Spooks Tech Post-Close; Chip Sector Sinks Further

U.S. equities ended Wednesday's regular session largely flat, but post-market trading saw a renewed wave of caution wash over the tech sector. Google parent GOOGL, despite reporting strong fourth-quarter revenue and EPS beats, saw its shares come under pressure. Investors reacted negatively to the company's aggressive 2026 capital expenditure forecast, targeting up to $185 billion primarily for its deepening AI investments, reigniting concerns about the immediate profitability and ROI of the AI race. This narrative extends the day's trend where the cost of AI growth was scrutinized, mirroring earlier investor reactions to Microsoft's (MSFT) own significant AI-related capex.

Adding to the tech sector's struggles, the semiconductor space faced a challenging evening. Chip supplier QCOM slid over 6% after hours, issuing a weak second-quarter revenue and profit forecast due to a global memory chip shortage impacting mobile sales. This compounded the day's earlier significant plunge in Advanced Micro Devices (AMD) and concerns around NVDA, whose AI chip sales to ByteDance reportedly face U.S. restrictions. ARM also fell post-earnings, highlighting the high bar for AI-centric companies. However, not all tech news was negative; PTC PTC surged on strong ARR growth and raised guidance, and CIEN celebrated its return to the S&P 500, citing AI-driven growth. Despite pockets of strength, particularly in pharma with LLY maintaining its robust rally, the overwhelming post-market sentiment for technology leans cautious as investors digest the heavy price tag of the AI revolution.

Google's AI Spending Spooks Tech Post-Close; Qualcomm Sinks

U.S. equities concluded a largely unchanged session today, with the S&P 500 flat. However, after-hours trading saw a significant divergence, particularly within the tech sector, as investors grappled with high-stakes AI spending and chip market headwinds. This extended the day's trend where major tech names like AMD plunged, while others sought perceived safety.

Despite beating fourth-quarter revenue and EPS estimates, GOOGL shares came under pressure in after-hours trading. The market reacted negatively to the Google parent's aggressive forecast for 2026 capital expenditures, targeting $175 billion to $185 billion, primarily for its deepening investments in the AI race. This massive spending plan reignited concerns about the immediate profitability of AI, echoing earlier scrutinies of Microsoft's (MSFT) own significant AI-related capex mentioned throughout the day.

Further dampening sentiment, chip supplier QCOM slid over 6% after-hours. The company issued a second-quarter revenue and profit forecast below Wall Street expectations, citing a global memory chip shortage that is impacting mobile phone sales. This added to earlier afternoon weakness in Broadcom (AVGO), which fell 4% on uncertainty surrounding high-end AI chip sales to China, and NVDA, whose AI chip sales to ByteDance reportedly face U.S. conditions.

However, not all tech news was negative. SNAP shares surged post-close after beating sales estimates, and E.l.f. ELF also rose after raising its annual forecasts on strong demand for affordable cosmetics. In other significant corporate moves, TXN announced a $7.5 billion acquisition of SLAB. While TXN saw a slight dip intraday, SLAB soared on the news. Elsewhere, O'ORLY tumbled on an earnings miss and weak guidance, while PayPYPL slid earlier on news of a new CEO. Job cuts continued to be a theme, with WDAY planning to reduce its workforce by 2% and broader reports of cuts at AMZN and UPS UPS.

Alphabet's AI Spending Spooks Tech Post-Close; Qualcomm Sinks, Snap Surges

U.S. equities concluded a largely unchanged session today, with the S&P 500 flat, but after-hours trading saw a significant divergence, particularly within the tech sector. Google parent GOOGL surprisingly came under pressure despite beating fourth-quarter revenue and EPS estimates. Investors reacted negatively to the company's aggressive 2026 capital expenditure forecast, targeting up to $185 billion for AI investments, raising concerns about the immediate profitability of the AI race.

Adding to the tech sector's struggles, chip supplier QCOM slid over 6% after hours, issuing a weak Q2 forecast due to a global memory chip shortage impacting mobile sales. This weighed on the broader semiconductor space. However, not all tech news was negative; SNAP shares surged after beating sales estimates, and E.l.f. ELF also rose after raising its annual forecasts on strong demand for cosmetics.

In other significant corporate moves, TXN announced a $7.5 billion acquisition of SLAB. While TXN saw a slight dip, SLAB soared on the news. This contrasted with ARM, which fell despite reporting record revenue. Meanwhile, companies like Tenable (TENB), Markel (MKL), and A10 Networks (ATEN) delivered strong post-market earnings beats, highlighting robust performance in other market segments. The conflicting signals from AI spending concerns and strong individual results leave investors with a choppy outlook heading into the next session.

AI Spending Fears Weigh Post-Market; Qualcomm Drags Chips

U.S. equities concluded a largely unchanged session today, with the S&P 500 flat. However, after-hours trading saw a renewed wave of caution, particularly in the tech sector, as investors grappled with high-stakes AI spending and chip market headwinds. This extended the day's trend where major tech names like AMD plunged, while others sought perceived safety.

Despite beating fourth-quarter revenue and EPS estimates, GOOGL shares came under pressure in after-hours trading. The market reacted negatively to the Google parent's aggressive forecast for 2026 capital expenditures, targeting $175 billion to $185 billion, primarily for its deepening investments in the AI race. This massive spending plan reignited concerns about the immediate profitability of AI, echoing earlier scrutinies of Microsoft's MSFT own significant AI-related capex mentioned throughout the day.

Further dampening sentiment, chip supplier QCOM saw its shares slide over 6% after-hours. The company issued a second-quarter revenue and profit forecast below Wall Street expectations, citing a global memory chip shortage that is impacting mobile phone sales. This added to earlier afternoon weakness in AVGO, which fell 4% on uncertainty surrounding high-end AI chip sales to China.

Elsewhere in post-market earnings, Yum! Brands (YUM) delivered mixed fourth-quarter results and announced that its Pizza Hut chain plans to close 250 underperforming restaurants, highlighting ongoing challenges in the restaurant sector. However, some individual names bucked the trend: ELF raised its annual forecasts on strong demand for affordable cosmetics, and Snap (SNAP) shares rose after beating sales estimates. Meanwhile, AAPL managed to gain during the regular session, acting as a potential haven amidst the broader tech sell-off. The overall message for tech remains complex: AI is driving growth, but the cost of that growth is increasingly a point of investor contention.

Tech Sell-off Deepens as AMD Plunges 16%; Pharma, Industrials Shine

U.S. equities concluded a deeply divergent session largely unchanged today, as a significant tech sector correction offset strong gains in pharmaceuticals, industrials, and utilities. The broader market's flat performance masked substantial underlying volatility and sector rotations.

The tech sector faced considerable headwinds, primarily driven by a staggering 16.7% plunge in semiconductor giant AMD. Its disappointing earnings forecast and a cautious outlook triggered widespread selling and intraday rebalances, pushing the Nasdaq notably lower. Concerns about AI's disruptive impact continued to weigh on software stocks, with reports of short sellers pocketing $24 billion from the sector's recent declines. Social media firm PINS also announced AI-driven layoffs, further highlighting the industry's restructuring. Counter-intuitively, AAPL bucked the tech trend, rallying as investors sought a perceived safe haven amidst AI disruption fears.

In contrast, pharmaceutical powerhouse LLY surged, extending its robust rally on blockbuster GLP-1 drug sales and strong 2026 guidance. This provided a stark contrast to earlier disappointing outlooks from competitors like Novo Nordisk. Elsewhere, energy markets reacted to geopolitical news, with oil prices jumping on reports of collapsing U.S.-Iran nuclear talks. Utilities and industrials also showed resilience, with VZ, D, HB Fuller (HBF), and AIT all hitting 52-week or all-time highs. Electric vehicle giant TSLA offered a mixed picture, reporting a 9% year-over-year rise in China shipments for January, even as it faced renewed competitive pressures in other markets. Data infrastructure play SNOW also saw positive momentum from its AI agent deployment at URI.

Market Flat; AMD Plunge Offsets Pharma & Industrial Gains

U.S. equities are treading water mid-afternoon, with the S&P 500 flat despite significant sector divergence driven by a flood of corporate earnings and macro signals. Beneath the surface, the market is battling fierce headwinds from a major tech correction while finding support in pharmaceuticals and industrials.

The tech sector is facing considerable pressure, with semiconductor giant AMD plunging a staggering 16.7% after its earnings forecast disappointed investors, triggering intraday rebalances across various exchange-traded products. This heavy sell-off is contributing to broader weakness in the Nasdaq. Adding to the mixed tech picture, MSFT saw its fair value trimmed by some analysts, citing higher AI-related capital spending, even as its revenue growth assumptions rose. TSLA presents a deeply mixed bag; while Wolfe Research issued a bullish long-term outlook for its Robotaxi business, recent reports indicate the company scrapped AV charging station plans and is facing fierce competition from BYD in the German market, where BYD's sales surged significantly. Meanwhile, AMZN is under watch ahead of its Q4 earnings report, with investors focused on capex and AI growth, as the company also expands its physical grocery footprint to rival Walmart (WMT).

Counterbalancing the tech drag are strong performances in other sectors. Pharmaceutical giant LLY continues its robust rally, with Deutsche Bank reiterating a Buy rating on strong 2026 guidance, fueled by its blockbuster GLP-1 drugs. Industrials are also providing support, with TKR surging after a Q4 earnings beat and REIT W.P. WPC hitting a 52-week high. Solar energy firm ENPH is also rallying on upbeat earnings and signs of residential solar demand bottoming out. Even with a notably weaker private payrolls report earlier today and Bitcoin falling to a 15-month low, the market remains in a state of choppy equilibrium as investors rotate between growth and value plays.

Market Stalls Amid Tech Drag; AMD Plunges While Pharma, Energy Climb

U.S. equities are treading water this afternoon, with the **S&P 500** flat despite a flurry of contrasting corporate headlines. The overall market is masking significant divergence beneath the surface, as tech heavyweights continue to face pressure while select pharmaceutical, energy, and industrial names advance.

Leading the downside in tech, semiconductor giant **AMD** is experiencing a significant plunge, down 16.7%, after its forecast miss hit shares and triggered intraday rebalances. This directly contradicts earlier optimism from CEO Lisa Su's remarks and reinforces a broader struggle for the Nasdaq, which is reportedly down 1% as tech stocks falter. Adding to the tech sector's woes, ONDS shares tumbled after JCapital Research cautioned on future prospects. All eyes are now on upcoming earnings reports from giants like AMZN and GOOGL, with investors scrutinizing AI and cloud growth amid a challenging environment for some parts of the sector.

Counterbalancing this tech weakness are strong performances elsewhere. LLY continues its upward trajectory, benefiting from robust GLP-1 drug sales, while solar energy firm ENPH is surging on upbeat earnings and a view that residential solar demand has bottomed. The energy and industrial sectors are also showing strength, with CVX, EIX, and REIT WPC all hitting 52-week highs. Strong earnings reports from FSV and TKR further highlight pockets of corporate health. Meanwhile, RBLX is gaining momentum after launching new AI tech to generate in-game models, and TSLA received a bullish long-term outlook for its Robotaxi business from Wolfe Research. Recent reports of **SpaceX** opening IPO pitching to non-US banks also provide a positive, albeit non-listed, sentiment boost.

AI Winners Drive Gains Amid Market Choppiness

The market is trading in a choppy range mid-morning, with overall equity indices hovering near flat despite a flurry of corporate earnings. While concerns over AI’s disruptive impact continue to weigh on traditional software names, specific artificial intelligence players are showing notable strength today, balancing out a mixed macro backdrop and individual disappointments.

Leading the charge is data analytics firm PLTR, which is surging after its CEO delivered a bullish message to investors, highlighting a superb 70% aggregate revenue growth in Q4, spearheaded by 93% growth in the U.S. Analysts are also bumping price targets, citing the company's unique AI implementation and integration model. Semiconductor giant AMD AMD also saw positive momentum as CEO Lisa Su addressed guidance concerns, stating that demand for its advanced chips and data center business is "still accelerating," potentially countering earlier pre-market weakness.

Further positive corporate news includes Fox (FOXA, FOX) beating quarterly revenue estimates on strong sports and Tubi performance, and Phillips 66 (PSX) posting a profit beat as refining margins climbed. Small-cap AI plays like CIGX are soaring on merger news with an AI firm, and Envirotech Vehicles (EVTV) rallied after advancing a data infrastructure initiative. On the flip side, persistent grocery inflation and sputtering car sales in January underscore broader economic headwinds, while Zillow (ZG) and Bright Horizons (BFAM) hit 52-week lows, illustrating sector-specific weaknesses.

Weak Jobs Data Fuels Early Market Choppiness Amid Mixed Earnings

U.S. equities are struggling for clear direction this morning, reacting to a significantly weaker-than-expected ADP jobs report that showed private payrolls rose by a paltry 22,000 in January, far short of expectations. This sluggish labor market data is clouding sentiment at the open, sparking debate over economic momentum and potential Fed policy shifts.

Against this macro backdrop, corporate earnings continue to drive divergent price action. Financials are seeing a boost, with futures exchange operator CME beating profit estimates on strong hedging demand, and UBS exceeding Q4 expectations while announcing a $3 billion buyback. Consumer names are also performing well, as YUM topped same-store sales estimates and MGM MGM surged after its BetMGM unit posted strong results. In pharma, the pre-market strength of Eli Lilly (LLY) is carrying over, a stark contrast to yesterday's grim outlook from Novo Nordisk (NVO).

The tech sector remains a mixed bag. Fintech firm SoSOFI is gaining after blowout earnings, with management emphasizing a shift towards capital-light, fee-based revenue. Cloudflare (NET) is also rising on an analyst upgrade. However, chipmaker AMD is notably lower following its earnings report, extending some of the pre-market tech weakness. Defense contractor RTX is hitting record highs after securing new Pentagon missile agreements, while TSLA faces renewed pressure from reports of plunging UK sales, despite earlier positive news on China sales and self-driving legislation efforts. Deutsche Bank also reaffirmed its aggressive $6,000 gold price target, suggesting conviction despite recent volatility in precious metals.

Jobs Data Disappoints Pre-Open; Eli Lilly Soars, Tech Mixed

U.S. equity futures are signaling a choppy open this Wednesday, influenced heavily by a weaker-than-expected labor market report and a flood of contrasting corporate earnings. The ADP report revealed private payrolls rose by a mere 22,000 in January, significantly missing expectations and potentially dampening inflation concerns but raising questions about economic momentum.

The pharmaceutical sector is experiencing a sharp divergence. LLY is set to open sharply higher after crushing quarterly estimates and issuing a robust outlook, driven by blockbuster sales of its GLP-1 drugs, Zepbound and Mounjaro. This stands in stark contrast to competitor NVO, which plunged on European exchanges following a grim 2026 outlook and anticipated pricing pressures on weight-loss drugs.

Meanwhile, the tech sector remains a battleground. Dow futures are showing gains amid a reported rotation out of technology into more defensive sectors like consumer staples and industrials. Chipmaker AMD AMD is indicated lower in pre-market trading after its earnings, while ride-hailing giant UBER also slides on a disappointing profit forecast despite record demand. Concerns about AI's disruptive impact continue to weigh on traditional software names. However, there are pockets of strength: TXN is making waves with a $7.5 billion acquisition of chip designer Silicon Labs (SLAB), while SMCI and Cloudflare (NET) are seeing pre-market pops following upbeat forecasts and analyst upgrades, respectively. Investors are bracing for volatility as they digest these varied inputs at the opening bell.

Pre-Market Mixed: Eli Lilly Soars, Tech Diverges

U.S. equity futures are signaling a choppy open this Wednesday, with Dow futures indicating gains as investors show signs of rotating out of tech and into consumer staples, regional banks, and industrials. This comes as the market grapples with a flood of earnings and lingering concerns over AI's disruptive impact on traditional software business models, even as other tech segments find support.

Pharmaceutical giant LLY is a clear pre-market winner, with its shares popping after blowing past quarterly estimates and posting a strong outlook, fueled by soaring sales of its GLP-1 drugs, Zepbound and Mounjaro. This stands in stark contrast to yesterday's grim outlook from competitor Novo Nordisk. Elsewhere, CTSH shares are rising after forecasting annual revenue above estimates, betting on robust AI-related IT services demand. Other positive earnings reports came from Equifax (EFX), Bio-Techne (TECH), and CDW (CDW), all topping expectations.

However, the tech sector remains bifurcated. Chipmaker AMD AMD is down significantly in pre-market trading after its earnings report, while UBER also saw shares fall following a first-quarter profit forecast below estimates, as cheaper rides impacted margins. These disappointments add to the broader anxiety felt by software stocks globally, as firms react to concerns that rapidly advancing AI tools could upend existing business models. Meanwhile, TXN made headlines with a $7.5 billion deal to acquire chip designer SLAB, expanding its wireless connectivity footprint. On the macro front, eurozone inflation cooled to 1.7% in January, a positive signal from overseas.

Pre-Market Choppy: Tech Diverges, Pharma Plunges on Outlook

U.S. equity futures are signaling a choppy open this Wednesday, with a significant divergence within the technology sector and continued pressure on specific pharmaceutical names. While earlier concerns about AI disruption in software stocks persist, fresh positive developments are providing a counterweight for other tech giants.

TSLA is set to benefit from the reported €1.06 trillion valuation of the combined SpaceX-xAI business, which bolsters the 'Musk trade' as his empire leans further into AI. Similarly, SNOW announced a significant $200 million AI partnership with OpenAI, providing a boost to sentiment. Semiconductor firm AMD AMD also received a price target upgrade from BofA Securities, citing strong growth potential. These positive catalysts are contending with lingering anxieties over AI's broader disruptive impact on traditional software business models.

In pharmaceutical news, NVO is experiencing a significant plunge on European exchanges, down as much as 17%, after its CEO indicated expectations for weight-loss drug pricing to decline, reinforcing an already grim 2026 outlook. This follows a stark contrast to earlier positive guidance from Amgen (AMGN). Elsewhere, Spanish banking giant SAN shares are falling after investors showed skepticism over its $12 billion U.S. bank acquisition. On the macro front, euro zone inflation cooled to 1.7% in January, offering a mild positive signal, while gold futures are showing strength, reclaiming the $5,000 level.

Tech Futures Drop as AI Disruption Fears Intensify; Pharma & Europe Mixed

U.S. equity futures are pointing lower this morning, extending yesterday's tech selloff as concerns around AI's disruptive potential continue to weigh heavily. Both S&P 500 and Nasdaq 100 futures are in negative territory, driven by a second day of plunges in global software and data analytics stocks following revelations about new, highly capable AI automation tools. European publishing and tech shares are also seeing declines, with investors reacting to how quickly AI could impact established business models.

The pharmaceutical sector presents a deeply bifurcated picture. NVO shares are down sharply in European trading after the CEO issued a grim 2026 outlook, disappointing investors. Conversely, Amgen (AMGN) is seeing strong pre-market interest after beating expectations and offering robust guidance, indicating selective strength in biotech.

Elsewhere in Europe, there's a mix of corporate news. ams OSRAM AMS shares are soaring after a significant sensor unit sale to Infineon (IFX), while Sumitomo Electric (SUMIF) surged on strong results. However, UBS is reportedly seeing more outflows from its U.S. wealth unit, and luxury retailer Watches of WOSG shares fell despite raised sales outlooks, as lower margin guidance spooked investors. Santander (SAN) also saw shares decline amid skepticism over its $12 billion U.S. bank deal.

On a slightly brighter note for tech, AMD AMD received multiple analyst price target boosts, citing server strength and growth potential. Prosus signed a multi-year AI deal with Amazon Web Services (AMZN), providing a positive headline for cloud infrastructure. Meanwhile, euro zone inflation cooled in January, offering a mild positive macro signal. Investors are bracing for a potentially choppy open, with the ongoing tech re-evaluation taking center stage.

Amgen Soars as Novo Nordisk Plunges; AI Doubts Persist for Tech

Wednesday's pre-market session is signaling a deeply bifurcated market as earnings continue to roll in. Pharmaceutical giant AMGN is seeing strong gains after beating expectations and issuing robust 2026 guidance, providing a welcome positive for the sector. However, this optimism is sharply contrasted by NVO, which plunged as much as 18% on European exchanges following a grim 2026 outlook from its CEO, adding to earlier cautious guidance from other pharma names like GSK.

Elsewhere, specific corporate disappointments are weighing on sentiment. CMG is sinking pre-market after a flat comparable sales forecast, while HIMX faces pressure from a Morgan Stanley downgrade citing non-AI weakness concerns. Even luxury retailer Watches of WOSGF, despite upgrading its sales guidance, saw shares fall as investors focused on lower margin forecasts. The broader tech sector continues to grapple with lingering AI disruption fears, which earlier impacted European publishing and software stocks, as well as chip names like AMD and concerns around Nvidia's China sales. Macro concerns also surfaced, with the FSB flagging risks in the $16 trillion repo market.

On a brighter note, TSLA reported a 9.3% year-over-year rise in China-made EV sales for January, offering some positive data for the EV giant. Insurance major ZURVY is also in focus, successfully acquiring Beazley with a sweetened $11 billion bid. As the market approaches open, investors are balancing these starkly divergent corporate performances against persistent sector-specific anxieties, particularly within tech and now a more mixed pharma landscape.

Novo Nordisk Plunges 18% on Grim Outlook; European Earnings Mixed

As Wednesday's pre-market session continues, global markets are grappling with a significant divergence in corporate earnings. Pharmaceutical giant NVO is seeing its shares plunge by a staggering 18% on European exchanges after its CEO warned of tougher times ahead, disappointing investors with a bleak 2026 forecast. This deepens the cautious sentiment already signaled by other pharma names like GSK GSK, which also anticipates slower sales growth for the coming year. Further adding to the downside, automotive chip supplier MLXS issued weak H1-26 guidance, citing cautious demand, while French banking giant ACA reported a sharp 39% drop in profit.

However, brighter spots are emerging elsewhere in Europe. Danish brewer Carlsberg (CARLb.CO) delivered better-than-expected annual profits, benefiting from cost-cutting measures, and luxury retailer Watches of Switzerland (WOSG.L) raised its annual sales forecast on robust demand. For U.S. investors, TSLA offers a positive data point, reporting a 9.3% year-over-year rise in China-made EV sales for January. The overarching narrative remains cautious, with lingering concerns about AI disruption and overall market valuations setting a choppy tone as the U.S. market approaches its open.

European Earnings Offer Mixed Signals; AI Doubts Linger for Tech

As Wednesday's pre-market unfolds, global markets continue to grapple with a divergence between strong individual corporate reports and persistent sector-specific headwinds. Following concerns about AI disruption in traditional software, the tech sector faced further pressure overnight. AMD's Frankfurt-listed shares declined after reporting weaker sales, while Nvidia's CEO addressed ongoing stock sell-offs amidst fears that AI tools could replace existing software. Adding to a cautious global sentiment, Bitcoin plunged to 15-month lows.

Across Europe, the earnings season delivered varied results. Swiss banking giant UBS posted a strong beat for its fourth quarter, announcing a substantial $3 billion share buyback plan. Danish brewer Carlsberg also exceeded profit forecasts, driven by cost-cutting measures. However, several pharmaceutical heavyweights, including Novartis, Novo Nordisk, and GSK, issued more subdued 2026 outlooks, pointing to slower sales growth or intensified competitive landscapes. Investors will weigh these diverging corporate prospects against the ongoing tech narrative as they await the U.S. market open.

AI Disruption Fears Intensify for Software; UBS Delivers Strong Earnings

Overnight trading highlighted a growing divergence in the AI narrative, as fears of disruptive artificial intelligence tools deepened the selloff in traditional software and data analytics sectors. Following earlier concerns about AI spending, new reports indicate that **Anthropic's** updated AI agents are seen as a direct threat, causing shares of companies like TRI to slump by nearly 18% in response. This extends the cautious sentiment that saw Asian software stocks plunge amid similar AI disruption anxieties.

However, the picture wasn't entirely bleak. Swiss banking giant **UBS** delivered a significant beat in its fourth-quarter earnings, with profit surging 56% and the company announcing a substantial $3 billion share buyback plan, offering a strong positive signal for the financial sector. In the tech space, companies enabling AI infrastructure continued to see optimism; ANET was in focus following renewed bullish sentiment around its role in AI data center buildouts for hyperscalers like **Meta (META)** and **Microsoft (MSFT)**. Gaming giant TTWO also reported a strong earnings beat and affirmed its Grand Theft Auto VI release while proactively addressing investor questions about AI disruption in game development.

Elsewhere, oil major EQNR saw its Q4 profit fall due to lower oil prices, adding a mixed note to the energy sector. As investors head into Wednesday's session, the primary focus remains on how AI will continue to reshape various industries, creating both significant winners and notable challenges.

AI Spending Doubts Hit Tech; Microsoft's Chip Bid Scrutinized

Overnight markets saw technology shares continue to grapple with concerns around AI profitability and spending. Following Tuesday's U.S. market close, these anxieties extended into Asian software stocks, which plunged amid fears of AI-led disruption.

MSFT unveiled its second-generation Maia 200 AI chip, a move aimed at bolstering its in-house AI infrastructure. However, investor sentiment remained cautious, weighing the heavy infrastructure costs and the company's significant exposure to OpenAI, which itself faces "significant hurdles" in achieving substantial ad sales. This skepticism echoed earlier reports of cautious insider selling and broader tech sector headwinds seen at Tuesday's close.

On a brighter note, F was reportedly in talks with China's Geely for a manufacturing and technology partnership, signaling potential expansion and collaboration opportunities for the automaker. Conversely, TCEHY shares faced pressure after its WeChat platform reportedly blocked red-envelope links from Yuanbao, while nLIGHT NLIT priced a public offering of common stock, often a dilutive event for existing shareholders.

Insider Selling Surges Post-Close; Tech Faces China Export Headwinds

As Tuesday's trading concluded and attention shifted to the overnight session, a significant wave of insider selling emerged, reinforcing concerns about current market valuations. Data indicated that corporate insiders are offloading shares at the fastest pace since 2021, suggesting caution from those closest to company fundamentals. This broader trend was mirrored by specific executive sales at major firms, including FTNT, where CEO Xie Ken sold $14.3 million in shares, CVX's CFO Bonner selling $5.6 million, and VZ (Verizon)'s EVP Russo offloading stock.

Adding to the cautious sentiment, the tech sector faced new challenges. NVDA saw its AI chip sales to China reportedly stalled amid a U.S. security review, a potential overhang for its growth trajectory. Meanwhile, AMZN confirmed further layoffs in Seattle, a move preceding its anticipated earnings report. On a slightly brighter note, BA offered some positive news, expecting to commence deliveries of its improved 787 Dreamliners in the first half of the year. These mixed signals, dominated by a pervasive insider selling narrative and tech-specific hurdles, set a cautious tone as investors look ahead to Wednesday's open.